Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

This study has been terminated.
(Regulatory decision not to proceed)
Sponsor:
Information provided by:
Amgen
ClinicalTrials.gov Identifier:
NCT00156962
First received: September 8, 2005
Last updated: July 17, 2008
Last verified: July 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)